Nanomedicine: Nanotechnology, Biology and Medicine
Original ArticleNanostructured SBA-15 silica: An effective protective vehicle to oral hepatitis B vaccine immunization
Graphical abstract
After proper oral immunization schedules using SBA-15 as adjuvant, the recruitment of inflammatory cells to Peyer’s patches and mesenteric lymph nodes and the enhanced production of specific antibodies, as well as the non-influence of silica in the polarization to TH1 or TH2 immune responses, were shown.
Section snippets
Animals
Female 8 to 12 week-old BALB/c mice, supplied by Butantan Institute animal facilities, were used to evaluate the adjuvant effect of SBA-15 silica toward oral immunizations. The experiments were conducted according to protocols approved by the Animal Use and Care Ethics Committee from the Butantan Institute (Protocol 672/09) and under ethical conditions according to the international rules of animal care by the International Animal Welfare Recommendations.38
SBA-15 silica synthesis and physical characterization
Mesoporous SBA-15 silica samples were
Incorporation analysis of HBsAg into nanostructured SBA-15 silica
Considering the dimension of HBsAg around 22 nm with more than 3000 kDa of molecular weight,41, 42 it is reasonable to suppose that the proteins are encapsulated inside the silica macroporosity (macropores larger than 50 nm, IUPAC), obstructing the entrance of the 10 nm mesopores.
Figure 1 presents the SAXS results, in particular, including the extra scattering factors (SC-Extra) related to the HBsAg presence in the silica matrix, according to the SAXS model of Reference,1 as well as the simulation
Discussion
Nature itself is definitively the major agent of vaccination, and the most important and efficacious memory promoter. Silica is the second most common element on earth, present in all environments, and as ordered nanostructures, it constitutes a variety of diatomaceous algae species, abundant in aquatic environments. The physical chemical characterization of the SBA-15 particles loaded with HBsAg was important to show the presence of the proteins in the silica macroporosity, as well to point
References (50)
- et al.
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15
Vaccine
(2010) - et al.
Regional specialization in the mucosal immune system: what happens in the microcompartments?
Immunol Today
(1999) - et al.
Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of immune stimulating complexes (ISCOMS)
Vaccine
(2002) Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies
Clin Immunol Immunopathol
(1995)(How) do aluminium adjuvants work?
Immunol Lett
(2006)- et al.
Adjuvants—a classification and review of their modes of action
Vaccine
(1997) - et al.
Mechanism of action of clinically approved adjuvants
Curr Opin Immunol
(2009) - et al.
Physiological considerations in the design of particulate dosage forms for oral vaccine delivery
Adv Drug Deliv Rev
(1998) - et al.
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G
Immunochemistry
(1971) - et al.
Phenotype and function of intestinal dendritic cells
Semin Immunol
(2005)
Physical properties of ordered mesoporous SBA-15 silica as immunological adjuvant
J Phys D
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Nature
Toward the synthesis of extra-large-pore MCM-41 analogues
Chem Mater
Morphogenesis of shapes and surface patterns in mesoporous silica
Nature
Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores
Science
Genetics of immunoresponsiveness to natural antigens in the mouse
Curr Top Microbiol Immunol
Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response
Small
Tuning mesoporous molecular sieve sba-15 for the immobilization of a-amylase
J Porous Mater
Naproxen drug delivery using periodic mesoporous silica SBA-15
Appl Surf Sci
Targeting of porous hybrid silica nanoparticles fo cancer cells
ACS Nano
Poly-l-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery
ACS Nano
Improving adsorbent properties of cage-like ordered amine functionalized mesoporous silica with very large pores for bioadsorption
Langmuir
Functionalized mesoporous silica with very large pores for cellulase immobilization
J Phys Chem C
Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles—opportunities & challenges
Nanoscale
Biocompatibility, biodistribution and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals
Small
Cited by (0)
This work was supported by funds in Brazil from the INCTTOX-CNPq/FAPESP Program, CeTICS-FAPESP (2013/07467-1), and Cristália Pharmaceutics. M.C.A. Fantini, C.L.P. Oliveira, M.T.D. Orlando, D.V. Tambourgi, and O.A. Sant’Anna are researchers of CNPq. Our thanks to Dr. E. Tenório for providing the protein concentrate of HBsAg. This research is under the scope of the International Patents WO07/030901, IN 248654, ZA 2008/02277, KR 1089400, MX 297263, HK 1124791, JP 5091863, CN 101287491B, CA 2621373, US 8642258 B2, and EP 1942934 B1.